SEROMYCIN- cycloserine capsule 
REMEDYREPACK INC.

----------

DESCRIPTION

CLINICAL PHARMACOLOGY

INDICATIONS & USAGE

CONTRAINDICATIONS

WARNINGS

PRECAUTIONS

LABORATORY TESTS

DRUG INTERACTIONS

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY

PREGNANCY

NURSING MOTHERS

PEDIATRIC USE

ADVERSE REACTIONS

OVERDOSAGE

DOSAGE & ADMINISTRATION

HOW SUPPLIED

REFERENCES

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION



MM2





SEROMYCIN 
cycloserine capsule
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:49349-018
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CYCLOSERINE (UNII: 95IK5KI84Z) (CYCLOSERINE - UNII:95IK5KI84Z) CYCLOSERINE250 mg
Inactive Ingredients
Ingredient NameStrength
D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
FD&C RED NO. 3 (UNII: PN2ZH5LOQY)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
GELATIN (UNII: 2G86QN327L)  
TALC (UNII: 7SEV7J4R1U)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
Colorred, grayScore2 pieces
ShapeCAPSULE (CAPSULE) Size20mm
FlavorImprint Code LILLY;F04
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:49349-018-0230 in 1 BLISTER PACK; Type 0: Not a Combination Product08/02/201108/02/2011
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA06059308/02/201108/02/2011
Labeler - REMEDYREPACK INC. (829572556)

Revised: 7/2016
Document Id: 36ea6ded-ace5-2f30-e054-00144ff88e88
Set id: 59cb6358-a75a-433b-ae13-4343797ca7d9
Version: 53
Effective Time: 20160705
 
REMEDYREPACK INC.